Overview Testosterone MD-Lotion Residual Washing Study Status: Completed Trial end date: 2010-02-01 Target enrollment: Participant gender: Summary The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure. Phase: Phase 1 Details Lead Sponsor: Acrux DDS Pty LtdTreatments: MethyltestosteroneTestosteroneTestosterone 17 beta-cypionateTestosterone enanthateTestosterone undecanoate